ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2648 • 2018 ACR/ARHP Annual Meeting

    Relationship between Damage and Mortality in Juvenile-Onset Systemic Lupus Erythematosus: Cluster Analyses in a Large Cohort from the Spanish Society of Rheumatology Lupus Registry

    JM Pego-Reigosa1, TC Salman-Monte2, Irene Altabás-González3, Iñigo Rúa-Figueroa4, Jacobo de Uña5, V Balboa-Barreiro6, Francisco Javier López Longo7, María Galindo8, Jaime Calvo-Alen9, Alejandro Olivé-Marqués10, Coral Mouriño-Rodriguez11, Eva Tomero12, Maria Loreto Horcada13, Ana Sánchez Atrio14, Carlos Alberto Montilla-Morales15, Eva Salgado16, Elvira Diez Alvarez17, Ricardo Blanco18, Jose Luis Andreu19, O Fernández-Berrizbeitia20, José Hernández Beiraín21, Marian Gantes22, Blanca Hernández-Cruz23, Angela Pecondon-Español24, Carlos Marras Fernandez-Cid25, María Gema Bonilla Hernán26, Jesús García-Villanueva27 and Vicente Torrente28, 1Complexo Hospitalario Universitario de Vigo, Vigo, Spain, 2Rheumatology, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain, 3Rheumatology, Hospital Doctor Negrin, Las Palmas GC, Spain, 4Rheumatology Division, Hospital Doctor Negrin, Las Palmas GC, Spain, 5Statistics and OR, Vigo University, Vigo, Spain, 6Department of Statistics and OR, Vigo University, Vigo (Spain), Vigo, Spain, 7Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 8Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, 9Rheumatology, Txagorritxu Hospital, Araba, Vitoria, Vitoria, Spain, 10Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 11Rheumatology, Rheumatology Section, Complexo Hospitalario Universitario de Vigo, Pontevedra, Spain, Vigo, Spain, 12Rheumatology, Hospital de La Princesa. Madrid. Spain, Madrid, Spain, 13Rheumatology, Hospital de Navarra, Pamplona, Spain, 14University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology Department, Alcalá de Henares, Madrid, Spain, 15Hospital Clínico Universitario de Salamanca. Spain, Salamanca, Spain, 16RheumatologyDepartment, Hospital Complex of Ourense, Ourense (Spain), Ourense, Spain, 17Complejo Asistencial Universitario de León, León, Spain, 18Rheumatology Department,, Hospital Marqués de Valdecilla, Santander, Spain, 19Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, 20Rheumatology Department Basurto Hospital, País Vasco, Basurto (Spain), Bilbao, Spain, 21Rheumatology, Hospital Insular de Gran Canaria, Las palmas Gran Canarias, Spain, 22Rheumatology, Hospital Universitario de Canarias, La Laguna; Tenerife, Spain, 23Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, 24Rheumatology, Hospital Miguel Servet, Zaragoza, Spain, 25Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain, 26Rheumatology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, 27HOSPITAL RAMÓN Y CAJAL, Madrid, Spain, 28Hospital de dia Baix de LLobregat, LLobregat, Spain

    Background/Purpose: To identify patterns (clusters) of damage manifestation within a large cohort of juvenile SLE (jSLE) patients and evaluate their possible association with mortality. Methods:…
  • Abstract Number: 2649 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Cancer in Systemic Lupus Erythematosus

    Ana Lucia Barbaglia1, Maria de la Paz Leon1, Luciana Gonzalez Lucero1, Raul Sueldo2, Maria Constanza Bertolaccini1, Francisco Javier Hüttmann1, Susana Mazza1, Yessika Soria Curi1, Maria Lilia Leguizamon1, Mirta Santana2, Liliana Galindo1, Ramiro Maldonado1, Veronica Bellomio1, Maria Victoria Collado3, Romina Rojas Tessel4, Aciar Mariana4 and Eleonora Lucero1, 1Hospital Angel C. Padilla, Tucuman, Argentina, 2Hospital Angel C. Padilla, Tucumán, Argentina, 3Lanari Institute, Buenos Aires, Argentina, 4Hospital del Milagro, Salta, Argentina

    - Background/Purpose:  Cancer is one of the main causes of morbidity and mortality worldwide. The overall risk of cancer in SLE is higher than in…
  • Abstract Number: 2650 • 2018 ACR/ARHP Annual Meeting

    Efficacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus

    Luca Iaccarino1, Francesca Saccon1, Alessandro Mathieu2, Matteo Piga3, Angela Ceribelli4, Carlo Selmi5, Paolo Cardinaletti6, Armando Gabrielli7, Andrea Di Matteo8, Rossella De Angelis9, Paola Faggioli10, Antonella Laria11, Micaela Fredi12, Francesca Regola13, Angela Tincani12, Laura Andreoli14, Giulia Pazzola15, Carlo Salvarani15, Francesco Puppo16, Ottavia Magnani16, Marcella Prete17, Elisa Gremese18, Maria Gerosa19, Tania Ubiali20, Enrica Bozzolo21, Valentina Canti21, Vito Racanelli17, Fabrizio Conti22, Fulvia Ceccarelli23, Elena Bartoloni24, Roberto Gerli25, Antonio Lobasso26, Amato de Paulis27, Ginevra De Marchi28, Salvatore De Vita29, Alessandra Bortoluzzi30, Marcello Govoni30, Francesco Benvenuti31, Margherita Zen32, Marta Mosca33, Chiara Tani34, Maurizio Rossini35, Giovanni Orsolini35, Salvatore Scarpato36, Ernico Brunetta37, Aurora Zumbo38, Giacomo Tanti39 and Andrea Doria40, 1Department of Medicine-DIMED, University of Padova, Padova, Italy, 2University of Cagliari, Cagliari, Italy, 3Unit and Chair of Rheumatology, University Hospital of Cagliari, Cagliari, Italy, 4Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (MI), Italy, 5Rheumatology and Clinical Immunology Unit, Humanitas Research Hospital, Rozzano (MI), Italy, 6University of Ancona, Ancona, Italy, 7Univeristy of Ancona, Ancona, Italy, 8Polytechnic University of Marche, Rheumatology Clinic, Jesi, Italy, 9Polytechnic University of Marche, Rheumatology Clinic, jesi, Italy, 10Hospital of Legnano, Legnano, Italy, 11Hospital of Magenta, Magenta, Italy, 12Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 13University of Brescia, Brescia, Italy, 14Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 15University of Reggio Emilia, Reggio Emilia, Italy, 16University of Genova, Genova, Italy, 17University of Bari, Bari, Italy, 18Division of Rheumatology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy, 19Istituto Ortopedico Gaetano Pini, University of Milan, Milano, Italy, 20Istituto Gaetano Pini, University of Milano, Milano, Italy, 21Hospital San Raffaele, Milano, Italy, 22Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy, 23UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Rome, Italy, 24Rheumatology Unit, University of Perugia, Perugia, Italy, 25Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, 26University Federico II of Napoli, Napoli, Italy, 27Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy, 28Hospital/University of Udine, Udine, Italy, 29Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy, 30UOC of Rheumatology, University Hospital S. Anna, Cona Ferrara, Italy, 31University of Padova, Padova, Italy, 32Division of Rheumatology, University of Padova, Padova, Italy, 33Rheumatology Unit, University of Pisa, Pisa, Italy, 34Univeristy of Pisa, Pisa, Italy, 35Rheumatology Unit, University of Verona, Verona, Italy, 36Hospital of Salerno, Salerno, Italy, 37Humanitas Hospital, Milano, Italy, 38Humnaitas Hospital, Milano, Italy, 39Catholic University of the sacred hearth, Roma, Italy, 40University and Azienda Ospedaliera of Padova, Padova, Italy

    Background/Purpose: To investigate effectiveness, safety, and predictors of response to belimumab in patients with active SLE in clinical practice setting. Methods: Four hundred and one…
  • Abstract Number: 2651 • 2018 ACR/ARHP Annual Meeting

    Patients Characteristics and Patters of Treatment in Refractory Systemic Lupus Erythematosus Patients in the Pre-Biologic Period: Data from a Multiethnic, Multinational Latin American Lupus Cohort

    Guillermo J. Pons-Estel1,2, Marina Scolnik3, Enrique R Soriano3, Guillermina Harvey4, Rosana Quintana5,6, Mercedes Garcia7, Verónica Saurit8, Cristina Drenkard9, Guillermo Berbotto10, Emilia Sato11, Lilian Costallat12, Eloisa Bonfa13, Eduardo Ferreira Borba14, Joao C. Tavares Brenol15, Nilzio A. da Silva16, Andre Cavalcanti17, Antonio Iglesias-Gamarra18, Marlene Guibert-Toledano19, Gil A. Reyes19, Loreto Massardo20, Oscar Neira21, Mario H Cardiel22, Leonor Barile23, Mary Carmen Amigo24, Luis H. Silveira25, Ignacio Garcia de la Torre26, Rosa Maria Serrano6, Eduardo Acevedo-Vasquez27, Manuel Ugarte-Gil27, Ines Segami28, Viviana Gervasoni5, Silvana Conti5, Rosa Chacón-Díaz29, Maria H Esteva-Spinetti30 and Bernardo A Pons-Estel6, 1Rheumatology, Hospital Provincial de Rosario, Rosario, Argentina, 2Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario. Argentina, Rosario, Argentina, 3Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, 4Escuela de Estadística, Universidad Nacional de Rosario, Rosario, Argentina, 5Hospital Provincial de Rosario, Rosario, Argentina, 6Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Rosario, Argentina, 7Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 8Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, 9Medicine/Rheumatology, Emory University, Atlanta, GA, 10Sanatorio Británico, Rosario, Argentina, 11Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 12Universidade Estadual da Campinas, Campinas, Brazil, 13Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 14Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 15Hospital da Clinicas da Porto Alegre, Porto Alegre, Brazil, 16Universidade Federal de Goiás, Goiânia, Brazil, 17Novartis, Sao Paulo, Brazil, 18Clinical Development, Nordic Bioscience, Herlev, Denmark, 19Centro de Investigaciones Médico-Quirúrgicas (CIMEQ), Havana, Cuba, 20GLADEL, Santiago, Chile, 21Rheumatology Section., Hospital del Salvador, Universidad de Chile., Santiago, Chile, 22Centro de Investigación Clínica de Morelia, Morelia, Mexico, 23Hospital Ángeles del Pedregal, Mexico, Mexico, 24Rheumatology, Centro Medico ABC, Mexico, Mexico, 25Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico, 26Hospital General de Occidente, Guadalajara, Mexico, 27Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, 28Hospital Edgardo Rebagliati Martins. EsSalud, Lima, Peru, 29Servicio de Reumatología, Hospital Universitario de Caracas, Centro Nacional de Enfermedades Reumáticas, Caracas, Venezuela, 30Hospital Central de San Cristóbal, San Cristóbal, Venezuela, San Cristóbal, Venezuela (Bolivarian Republic of)

    Background/Purpose: Over the last few years, the importance of treating patients with systemic lupus erythematosus (SLE) towards achieving Remission or Low Disease Activity State has…
  • Abstract Number: 2652 • 2018 ACR/ARHP Annual Meeting

    Engaging the Cholinergic Anti-Inflammatory Pathway By Stimulating the Vagus Nerve Reduces Pain and Fatigue in Patients with SLE

    Cynthia Aranow1, Martin Lesser2, Meggan Mackay1, Erik Anderson3, Theodoros P. Zanos2, Timir Datta-Chaudhuri2, Chad Bouton2, Kevin J. Tracey4 and Betty Diamond1, 1The Feinstein Institute for Medical Research, Manhasset, NY, 2Feinstein Institute for Medical Research, Manhasset, NY, 3Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, NY, 4Laboratory of Biomedical Science, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose:   Musculoskeletal (MS) pain is a common symptom of patients with Systemic Lupus Erythematosus (SLE) affecting up to 95% of patients and contributing to…
  • Abstract Number: 2653 • 2018 ACR/ARHP Annual Meeting

    Contraceptive Documentation in Systemic Lupus Erythematosus Patients at a Safety Net Hospital

    Ola Azzouqah1 and Bonnie L. Bermas2, 1Department of Rheumatic diseases, UT Southwestern Medical Center and Parkland Hospital, Dallas, TX, 2Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: Systemic Lupus Erythematosus (SLE) predominately affects reproductive aged women. Contraceptive counseling is an important quality indicator in SLE patient care. Here we evaluate current…
  • Abstract Number: 2654 • 2018 ACR/ARHP Annual Meeting

    Exposure to Air Pollution and the Onset and Progression of Systemic Lupus Erythematosus

    Gaurav Gulati1, Cole Brokamp2, Patrick Ryan2 and Hermine I. Brunner3, 1Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, OH, 2Department of Biostatistics and Epidemiology, Cincinnati Childrens Hospital and Medical Center, Cincinnati, OH, 3Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Air pollution may contribute to many autoimmune diseases including systemic lupus erythematosus (SLE), but limited information is available on its role in the onset…
  • Abstract Number: 2655 • 2018 ACR/ARHP Annual Meeting

    SLE-Key® Ruleout Testing in Support of Patient Triage in the Clinical Rheumatology Setting

    Steve Wallace1, Giovani Geslani2, Joanna Geslani2, Michael Strachan3, Don Thomas4, Korey Ullrich5, Alvin F. Wells6, Emileigh Wong1, Maggie Barton1 and Pennina Safer7, 1ImmunArray Inc., Richmond, VA, 2Rheumatology Associates Arlington, Arlington, TX, 3Premier Healthcare Associates, Richmond, VA, 4Arthritis & Pain Associates of P. G. County, Greenbelt, MD, 5Rheumatology Associates of South Florida, Boca Raton, FL, 6Rheumatology and Immunotherapy Center, Franklin, WI, 7ImmunArray Ltd., Rehovot, Israel, Rehovot, Israel

    Background/Purpose: SLE diagnosis and classification can be challenging. The low incidence of SLE limits primary care physician experience with the disease, but the impact of…
  • Abstract Number: 2656 • 2018 ACR/ARHP Annual Meeting

    Apremilast As Treatment of Refractory Skin Lupus Lesions

    José Luis Martín-Varillas1, Belén Atienza-Mateo1, Javier Loricera2, Monica Calderón Goercke3, Diana Prieto Peña3, Susana Armesto2, Eduardo Cuende4, Carmen González-Vela2, José Luis Hernández2, Miguel Angel González-Gay2 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 4University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology department, Alcalá de Henares, Madrid, Spain

    Background/Purpose: Skin lesions of lupus may be refractory to standard therapy. Apremilast is an orally small molecule which inhibits phosphodiesterase-4 (PDE-4) that modulates some inflammatory…
  • Abstract Number: 2657 • 2018 ACR/ARHP Annual Meeting

    Assessment of Habitual Physical Activity and Performance during Maximal Exercise Test in Systemic Lupus Erythematosus Patients

    Rosane Machado1, Nilzio A. da Silva1,2, Vitalina Barbosa1, Jozelia Rêgo1, Heloísa Machado1, Claúdio Lira1 and Ricardo Viana1, 1Universidade Federal de Goiás, Goiânia, Brazil, 2GLADEL, Goias, Brazil

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) present low physical capacity when compared to healthy controls. In addition to chronotropic incompetence during exercise, slow recovery…
  • Abstract Number: 2658 • 2018 ACR/ARHP Annual Meeting

    Real World Medication Use in Incident Systemic Lupus Erythematosus and Lupus Nephritis Patients

    Lin Xie1, Furaha Kariburyo1, Janvi Sah1, Jennifer Lofland2 and Nan Li3, 1STATinMED Research Inc., Ann Arbor, MI, 2Janssen Scientific Affairs, LLC, Horsham, PA, 3Janssen Research & Development, LLC, Spring House, PA

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease that causes inflammation in connective tissues and can involve multiple organs systems. Lupus nephritis (LN) is…
  • Abstract Number: 2659 • 2018 ACR/ARHP Annual Meeting

    Clinical Features, Damage Accrual and Survival in Patients with Familial Systemic Lupus Erythematosus (SLE): Data from a Multiethnic, Multinational Latin American Lupus Cohort

    Rosana Quintana1,2, Guillermo J. Pons-Estel3,4, Karen Roberts1, Mónica Sacnun5, Rosa Maria Serrano2, Romina Nieto1, Silvana Conti1, Viviana Gervasoni1, Luis J. Catoggio6, Enrique R Soriano7, Marina Scolnik7, Mercedes Garcia8, Alejandro Alvarellos9, Verónica Saurit10, Guillermo Berbotto11, Emilia Sato12, Lilian Costallat13, Eduardo Borba14, Eloisa Bonfa15, Ricardo M. Xavier16, Ana Carolina de Oliveira e Silva17, JF Molina18, Antonio Iglesias-Gamarra19, Marlene Guibert-Toledano20, Gil A. Reyes20, Loreto Massardo21, Oscar J Neira22, Mario H Cardiel23, Leonor Barile24, Mary Carmen Amigo25, Luis H. Silveira26, Ignacio Garcia de la Torre27, Eduardo Acevedo-Vasquez28, Manuel Ugarte-Gil29, Jose Alfaro-Lozano30, Ines Segami31, Rosa Chacón-Díaz32, Maria H Esteva Spinetti33, Jose A Gómez-Puerta34, Graciela S. Alarcón35 and Bernardo A Pons-Estel2, 1Hospital Provincial de Rosario, Rosario, Argentina, 2Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Rosario, Argentina, 3Rheumatology, Hospital Provincial de Rosario, Rosario, Argentina, 4Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario. Argentina, Rosario, Argentina, 5Rheumatology Section, Hospital Provincial de Rosario, Rosario, Argentina, 6Rheumatology Unit, Internal Medicine Service. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 7Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, 8Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 9Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, 10Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, 11Hospital Escuela Eva Perón, Granadero Baigorria, Argentina, Granadero Baigorria, Argentina, 12Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 13Universidade Estadual da Campinas, Campinas, Brazil, 14Faculdade de Medicina, Hospital das Clínicas. Universidade de São Paulo, São Paulo, Brazil, 15Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 16Universidade Federal do Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil, 17Faculdade de Medicina, Universidade Federal de Goias, Goiania, Brazil, 18Reumalab, Medellín, Colombia, 19Clinical Development, Nordic Bioscience, Herlev, Denmark, 20Centro de Investigaciones Médico-Quirúrgicas (CIMEQ), Havana, Cuba, 21GLADEL, Santiago, Chile, 22Hospital del Salvador, Facultad de Medicina, Universidad de Chile, Santiago, Chile, 23Centro de Investigación Clínica de Morelia, Morelia, Mexico, 24Hospital Ángeles del Pedregal, Mexico, Mexico, 25Rheumatology, Centro Medico ABC, Mexico, Mexico, 26Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico, 27Hospital General de Occidente, Guadalajara, Mexico, 28Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, 29Rheumatology, Universidad Científica del Sur, Lima, Peru, 30Rheumatology, Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, 31Hospital Edgardo Rebagliati Martins. EsSalud, Lima, Peru, 32Servicio de Reumatología, Hospital Universitario de Caracas, Centro Nacional de Enfermedades Reumáticas, Caracas, Venezuela, 33Hospital Central de San Cristóbal, San Cristobal, Venezuela (Bolivarian Republic of), 34Rheumatology Department, Hospital Clínic, Barcelona, Spain, 35Universidad Peruana Cayetano Heredia, Lima, Peru

    Background/Purpose: GLADEL (Grupo Latino Americano De Estudio de Lupus) has previously shown that a 14.1% of its patients have relatives with an autoimmune disease (1).…
  • Abstract Number: 2660 • 2018 ACR/ARHP Annual Meeting

    Low-Dose Interleukin-2 Treatment of Refractory Lupus Nephritis

    Xia Zhang1 and Jing He2, 1Department of Rheumatology & immunology, Peking University People's Hospital, Beijing, China, 2Rheumatology, Peking University People's Hospital, Beijing, China

    Background/Purpose: Lupus nephritis (LN) is a common and serious organ manifestation of SLE and is associated with substantial patient morbidity and mortality. The production of…
  • Abstract Number: 2661 • 2018 ACR/ARHP Annual Meeting

    Metformin Combined with Conventional Therapy Increases Absolute Number of Regulatory T Cells in Patients with Systemic Lupus Erythematosus

    Meihua Hao1, Zhaoyun Liang2, Xiaona Jing2, Chong Gao3, Xiao-Feng Li4 and Junwei Chen2, 1The second Hospital of Shanxi Medical University, TaiYuan, China, 2The Second Hospital of Shanxi Medical University, Taiyuan, China, 3Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Cambridge, MA, 4Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China

    Background/Purpose:To observe the clinical efficacy of metformin in the treatment of SLE and regulation of CD4+ Treg and Th17 cells.Methods:Thirty-one patients with SLE, fulfilled the ACR…
  • Abstract Number: 2662 • 2018 ACR/ARHP Annual Meeting

    Changes in Blood Pressure and Proteinuria at One Year in Two Lupus Nephritis Clinical Trials

    L. Michelle Gomez Mendez1, Marco Prunotto2, Jian Dai3, Paul Brakeman1, Maria Dall'Era1, Jay Garg3 and Matthew Cascino3, 1UCSF, San Francisco, CA, 2Hoffmann-La Roche, Basel, Switzerland, 3Genentech, Inc., South San Francisco, CA

    Background/Purpose: Hypertension predicts poor long-term renal outcomes for patients with lupus nephritis (LN) [1, 2]. We sought to characterize relationships between blood pressure and proteinuria…
  • « Previous Page
  • 1
  • …
  • 1179
  • 1180
  • 1181
  • 1182
  • 1183
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology